Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305

Introduction. Cirrhosis is a chronic degenerative illness characterized by changes in normal liver architecture, failure of hepatic function, and impairment of proliferative activity. The aim of this study is to know how IFC-305 compound induces proliferation of the liver during reversion of cirrhos...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Chagoya de Sánchez, Lidia Martínez-Pérez, Rolando Hernández-Muñoz, Gabriela Velasco-Loyden
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Hepatology
Online Access:http://dx.doi.org/10.1155/2012/212530
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566601885417472
author Victoria Chagoya de Sánchez
Lidia Martínez-Pérez
Rolando Hernández-Muñoz
Gabriela Velasco-Loyden
author_facet Victoria Chagoya de Sánchez
Lidia Martínez-Pérez
Rolando Hernández-Muñoz
Gabriela Velasco-Loyden
author_sort Victoria Chagoya de Sánchez
collection DOAJ
description Introduction. Cirrhosis is a chronic degenerative illness characterized by changes in normal liver architecture, failure of hepatic function, and impairment of proliferative activity. The aim of this study is to know how IFC-305 compound induces proliferation of the liver during reversion of cirrhosis. Methods. Once cirrhosis has been installed by CCl4 treatment for 10 weeks in male Wistar rats, they were divided into four groups: two received saline and two received the compound; all were euthanized at 5 and 10 weeks of treatment. Liver homogenate, mitochondria, and nucleus were used to measure cyclins, CDKs, and cell cycle regulatory proteins PCNA, pRb, p53, E2F, p21, p27, HGF, liver ATP, and mitochondrial function. Results. Diminution and small changes were observed in the studied proteins in the cirrhotic animals without treatment. The IFC-305-treated rats showed a clear increase in most of the proteins studied mainly in PCNA and CDK6, and a marked increased in ATP and mitochondrial function. Discussion/Conclusion. IFC-305 induces a recovery of the cell cycle inhibition promoting recovery of DNA damage through the action of PCNA and p53. The increase in energy and preservation of mitochondrial function contribute to recovering the proliferative function.
format Article
id doaj-art-2f7c170281e84be89ed2cb9bcfbd444b
institution Kabale University
issn 2090-3448
2090-3456
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Hepatology
spelling doaj-art-2f7c170281e84be89ed2cb9bcfbd444b2025-02-03T01:03:38ZengWileyInternational Journal of Hepatology2090-34482090-34562012-01-01201210.1155/2012/212530212530Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305Victoria Chagoya de Sánchez0Lidia Martínez-Pérez1Rolando Hernández-Muñoz2Gabriela Velasco-Loyden3Departmento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, MexicoDepartmento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, MexicoDepartmento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, MexicoDepartmento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, MexicoIntroduction. Cirrhosis is a chronic degenerative illness characterized by changes in normal liver architecture, failure of hepatic function, and impairment of proliferative activity. The aim of this study is to know how IFC-305 compound induces proliferation of the liver during reversion of cirrhosis. Methods. Once cirrhosis has been installed by CCl4 treatment for 10 weeks in male Wistar rats, they were divided into four groups: two received saline and two received the compound; all were euthanized at 5 and 10 weeks of treatment. Liver homogenate, mitochondria, and nucleus were used to measure cyclins, CDKs, and cell cycle regulatory proteins PCNA, pRb, p53, E2F, p21, p27, HGF, liver ATP, and mitochondrial function. Results. Diminution and small changes were observed in the studied proteins in the cirrhotic animals without treatment. The IFC-305-treated rats showed a clear increase in most of the proteins studied mainly in PCNA and CDK6, and a marked increased in ATP and mitochondrial function. Discussion/Conclusion. IFC-305 induces a recovery of the cell cycle inhibition promoting recovery of DNA damage through the action of PCNA and p53. The increase in energy and preservation of mitochondrial function contribute to recovering the proliferative function.http://dx.doi.org/10.1155/2012/212530
spellingShingle Victoria Chagoya de Sánchez
Lidia Martínez-Pérez
Rolando Hernández-Muñoz
Gabriela Velasco-Loyden
Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
International Journal of Hepatology
title Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
title_full Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
title_fullStr Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
title_full_unstemmed Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
title_short Recovery of the Cell Cycle Inhibition in CCl4-Induced Cirrhosis by the Adenosine Derivative IFC-305
title_sort recovery of the cell cycle inhibition in ccl4 induced cirrhosis by the adenosine derivative ifc 305
url http://dx.doi.org/10.1155/2012/212530
work_keys_str_mv AT victoriachagoyadesanchez recoveryofthecellcycleinhibitioninccl4inducedcirrhosisbytheadenosinederivativeifc305
AT lidiamartinezperez recoveryofthecellcycleinhibitioninccl4inducedcirrhosisbytheadenosinederivativeifc305
AT rolandohernandezmunoz recoveryofthecellcycleinhibitioninccl4inducedcirrhosisbytheadenosinederivativeifc305
AT gabrielavelascoloyden recoveryofthecellcycleinhibitioninccl4inducedcirrhosisbytheadenosinederivativeifc305